-+ 0.00%
-+ 0.00%
-+ 0.00%
Cornerstone Pharmaceutical-B (02616) granted a total of 960,000 share options and 640,000 restricted share units
Share
Listen to the news

Zhitong Finance App News, Cornerstone Pharmaceutical-B (02616) issued an announcement. On November 20, 2026, the board of directors resolved to grant a total of 960,000 share purchase rights to eight share option grantees in accordance with the terms of the initial public offering after-sales employee share ownership plan.

On November 20, 2026, the board of directors resolved to grant a total of 640,000 restricted share units to eight restricted share unit grantees in accordance with the terms of the restricted share award scheme after the initial public offering.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending